AVIDEA TECHNOLOGIES
Avidea Technologies is a developer of polymer-based drugs intended to provide vaccines for cancer treatment and infectious diseases.The company's drugs are packed as nanoparticles of uniform size that are designed to target specific tissues and cell populations, enabling patients to have fast recovery options instead of off-target side effects.
AVIDEA TECHNOLOGIES
Social Links:
Industry:
Biotechnology Oncology
Founded:
2013-01-01
Address:
Baltimore, Maryland, United States
Country:
United States
Website Url:
http://www.avideatechnologies.com
Total Employee:
11+
Status:
Active
Technology used in webpage:
Google Maps U.S. Server Location COVID-19
Similar Organizations
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
ExpressCells
ExpressCells creates custom cell lines for biological research and drug discovery.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Imvax
Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.
Longevity Biotech
Longevity Biotech develops a new class of therapeutics via artificial protein technology that focuses on pharmaceutical preparation.
Oncora Medical
Oncora Medical is a digital health company integrating big data and machine learning into radiation oncology.
Pinpoint Therapeutics
Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.
Stabiliz Orthopaedics
Stabiliz Orthopaedics develops novel enhancements for orthopedic medical devices using FDA-approved technologies.
Founder
Investors List
Johns Hopkins Technology Ventures
Johns Hopkins Technology Ventures investment in Venture Round - Avidea Technologies
Official Site Inspections
http://www.avideatechnologies.com
- Host name: server-52-85-151-112.iad89.r.cloudfront.net
- IP address: 52.85.151.112
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Avidea Technologies"
Avidea Technologies Company Profile 2024: Valuation, Investors ...
Avidea Technologies General Information Description. Developer of immunotherapies intended to treat cancer and autoimmune diseases. The company offers polymer-drug conjugate …See details»
Avidea Technologies, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Avidea Technologies, Inc. of Baltimore, MD. Get the latest business insights from Dun & Bradstreet.See details»
Avidea Technologies acquired by Barinthus Biotherapeutics
Dec 14, 2021 Avidea Technologies Avidea Technologies is a developer of polymer-based drugs intended to provide vaccines for cancer treatment and infectious diseases. Acquiring …See details»
Longtime FastForward Startup’s Acquisition Caps …
Mar 11, 2022 Avidea Technologies, which develops T cell immunotherapies to treat cancer and autoimmune diseases, was acquired by Vaccitech, a British drug and vaccine maker, in December 2021 for $40 million. The deal was the …See details»
Avidea Technologies - Org Chart, Teams, Culture & Jobs - The Org
Avidea Technologies is a developer of polymer-based drugs intended to provide vaccines for cancer treatment and infectious diseases.The company's drugs are packed as nanoparticles …See details»
Avidea Technologies - Funding, Financials, Valuation & Investors
Jan 1, 2018 Avidea Technologies is a developer of polymer-based drugs intended to provide vaccines for cancer treatment and infectious diseases. Search Crunchbase. ... How much …See details»
Vaccitech acquires Avidea Technologies to expand product
Dec 14, 2021 Vaccitech acquires Avidea Technologies to expand product Details Published: Tuesday, December 14, 2021 OXFORD, United Kingdom, and BALTIMORE, Dec. 13, 2021 …See details»
Vaccitech acquires Avidea Technologies to expand product
Dec 13, 2021 Vaccitech acquires Avidea Technologies to expand product pipeline and strengthen scientific leadership in immunotherapies and vaccines Published Dec 13, 2021 …See details»
Vaccitech acquires Avidea Technologies to expand product …
Dec 13, 2021 A conference call and webcast will be held on December 14, 2021, at 8:30 a.m. EST (1:30 p.m. GMT). The webcast link and presentation can be found on the Events section …See details»
Johns Hopkins spinout Avidea was acquired by UK company …
Dec 16, 2021 UK biopharmaceutical company Vaccitech has acquired Johns Hopkins spinout Avidea Technologies in a deal valued at $40 million.. Vaccitech developed the technology …See details»
Vaccitech acquires Avidea Technologies to expand product …
Dec 13, 2021 OXFORD, United Kingdom, and BALTIMORE, Dec. 13, 2021 — Vaccitech plc (NASDAQ: VACC), a clinical-stage biopharmaceutical company engaged in the discovery and …See details»
Vaccitech acquires Avidea Technologies to expand product
Dec 13, 2021 About Avidea Technologies Avidea is a privately-held biotechnology company that is advancing the next generation of safer and more effective T cell immunotherapies for …See details»
Avidea's SNAPvax™ Tolerance Vaccine Program Boosted by SAB …
BALTIMORE, June 14, 2021 /PRNewswire/ -- Avidea Technologies, Inc. ("Avidea"), a biotechnology company developing 'precision' immunotherapies for cancer and autoimmunity, …See details»
Avidea Technologies and Collaborators Publish Results in Nature ...
Nov 4, 2020 About Avidea Technologies: Avidea Technologies is a biotechnology company developing novel immunotherapies that aim to provide unprecedented control over the …See details»
Avidea Technologies - Contacts, Employees, Board Members
Avidea Technologies is a developer of polymer-based drugs intended to provide vaccines for cancer treatment and infectious diseases. Search Crunchbase Start Free TrialSee details»
SYN 001 - Avidea Technologies - AdisInsight - Springer
13 Dec 2021 Avidea Technologies has been acquired by Vaccitech 17 Sep 2021 SYN 001 - Avidea Technologies is available for partnering as of 31 Aug 2021. …See details»
Vaccitech acquires Avidea Technologies to expand product
Dec 13, 2021 About Avidea Technologies. Avidea is a privately-held biotechnology company that is advancing the next generation of safer and more effective T cell immunotherapies for …See details»
Avidea Technologies Utilizes GenScript's Synthesized Neoantigen ...
Jan 17, 2020 Groundbreaking research published in Nature Biotechnology highlights a novel neoantigen vaccine that demonstrates stronger anti-tumor immunity than traditional cancer …See details»
Vaccitech acquires Avidea Technologies to expand product …
Dec 14, 2021 About Avidea Technologies. Avidea is a privately-held biotechnology company that is advancing the next generation of safer and more effective T cell immunotherapies for …See details»